In this analysis, five biomarkers, PTPN1, COPZ1, FAXDC2, SLC14A1s and NAMPT were identified as the best group of markers for distinguishing PSP from HC with an overall diagnostic accuracy of 69% (Table 3). Here, COPZ1 is linked to supranuclear palsy, progressive, 1.